Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Background/objectives Reduced consumption of trans-fatty acids (TFA) is desirable to lower coronary heart disease (CHD) risk. In practice, partially hydrogenated vegetable oils (PHVO) that contain both TFAs and other fatty acids are the unit of replacement and could be replaced with diverse alternative fats and oils. We performed quantitative estimates of CHD effects if a person's PHVO consumption were to be replaced with alternative fats and oils based on (1) randomized dietary trials and (2) prospective observational studies.Subjects/methods We performed meta-analyses of (1) the effects of TFAs on blood lipids and lipoproteins in controlled dietary trials and (2) associations of habitual TFA consumption with CHD outcomes in prospective cohort studies. On the basis of these results and corresponding findings for saturated fatty acids (SFA), cis-monounsaturated fatty acids (MUFA) and cis-polyunsaturated fatty acids (PUFA), we calculated the effects on CHD risk for replacing 7.5% of energy from three different PHVO formulations (containing 20, 35 or 45% TFAs) with butter, lard, palm or vegetable oils.Results In controlled trials, each 1% energy replacement of TFAs with SFAs, MUFAs or PUFAs, respectively, decreased the total cholesterol (TC)/high-density lipoprotein cholesterol (HDL-C) ratio by 0.31, 0.54 and 0.67; the apolipoprotein (Apo)-B/ApoAI ratio by 0.007, 0.010 and 0.011; and lipoprotein (Lp)(a) by 3.76, 1.39 and 1.11 mg/l (P<0.05 for each). We also included possible effects on C-reactive protein (CRP) of TFAs vs other fats from one trial. On the basis of these risk factor changes in controlled trials, CHD risk would be variably decreased by different fats and oils replacing 7.5% of energy from 20% TFA PHVO (CHD risk reduction: -2.7% (butter) to -9.9% (canola)); 35% TFA PHVO (-11.9% (butter) to -16.0% (canola)); or 45% TFA PHVO (-17.6% (butter) to -19.8% (canola)). In prospective cohort studies, each 2% energy replacement of TFAs with SFAs, MUFAs or PUFAs would lower CHD risk by 17% (95% confidence interval (CI)=7-25%), 21% (95% CI=12-30%) or 24% (95% CI=15-33%), respectively. On the basis of these associations in observational studies, CHD risk would be variably decreased by different fats and oils replacing 7.5% of energy from 20% TFA PHVO (CHD risk reduction: +0.5% (butter) to -21.8% (soybean)); 35% TFA PHVO (-14.4% (butter) to -33.4% (soybean)); or 45% TFA PHVO (-22.4% (butter) to -39.6% (soybean)). The demonstrated effects on TC/HDL-C, ApoB/ApoAI, Lp(a), and CRP in randomized feeding trials together accounted for approximately 65-80% and approximately 50% of the estimated risk reduction for replacing PHVO with animal fats and vegetable oils, respectively, that would be calculated from prospective cohort studies.Conclusions Effects on CHD risk of removing PHVO from a person's diet vary depending on the TFA content of the PHVO and the fatty acid composition of the replacement fat or oil, with direct implications for reformulation of individual food products. Accounting for the summed effects of TFAs on multiple CHD risk factors provides more accurate estimates of potential risk reduction than considering each risk factor in isolation, and approaches the estimated risk reduction derived from prospective cohort studies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Replacing 1% energy of trans fatty acids with saturated, monounsaturated, or polyunsaturated fatty acids decreases the total cholesterol/HDL cholesterol ratio by 0.31, 0.54, and 0.67, respectively.283”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [283]
In the citing paper
“Substituting calories from mono- or poly-unsaturated fat with trans fatty acids increases LDL cholesterol, apolipoprotein B, triglycerides, and lipoprotein(a), and lowers plasma high-density lipoprotein cholesterol and apolipoprotein A1 levels (44).”
From Health Benefits of the Mediterranean Diet: Metabolic and Molecular Mechanisms (2018) · cites this paper as [44]
In the citing paper
“Weight loss has a beneficial effect on lipids and lipoproteins.”
From Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association (2011) · cites this paper as [385]
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · cited 1×
“Summary estimates were obtained using random effects meta-analysis weighted by the inverse variance log RRs of the individual studies (DerSimonian and Laird, 1986).”
MethodYusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Danesh, J., Wheeler, J. G., Hirschfield, G. M., Eda, S., Eiriksdottir, G., Rumley, A., Lowe, G. D. O., Pepys, M. B., & Gudnason, V. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032804 · Cited by 2,953 · cited 2×
“For an estimated 1.2 mg/l higher CRP, the RR was 1.58 (95% CI¼1.48–1.68) (Danesh et al., 2004).”
MethodInfluentialMensink, R. P., Zock, P. L., Kester, A. D., & Katan, M. B. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.5.1146 · Cited by 2,811 · cited 1×
“The effects on blood lipid concentrations of isocaloric changes between consumption of SFAs, MUFAs and PUFAs were calculated from a prior meta-analysis of randomized controlled dietary trials (Mensink et al., 2003).”
Method(2007) · The Lancet · doi:10.1016/s0140-6736(07)61778-4 · Cited by 2,331 · cited 3×
“For a 1.33 decrease in the TC/HDL-C ratio, the relative risk (RR) of CHD (weighted across age groups) was 0.61 (95% confidence interval (CI)¼0.55–0.69) after correction for regression dilution bias (Prospective Studies Collaboration, 2007).”
BackgroundMethodInfluentialDietary Fat Intake and the Risk of Coronary Heart Disease in Women
Hu, F. B., Stampfer, M. J., Manson, J. E., Rimm, E., Colditz, G. A., Rosner, B. A., Hennekens, C. H., & Willett, W. C. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711203372102 · Cited by 1,782
Trans fatty acids and cardiovascular disease
Mozaffarian, D., Katan, M. B., Ascherio, A., Stampfer, M. J., & Willett, W. C. (2006) · New England Journal of Medicine · doi:10.1056/nejmra054035 · Cited by 1,752 · cited 11×
“…controlled feeding trials and of associations of habitual TFA consumption with clinical endpoints in prospective cohort studies, the estimated effects on CHD risk of replacing TFAs with equivalent calories from carbohydrate or cis-unsaturated fats has been estimated (Mozaffarian et al., 2006).”
BackgroundResultInfluentialSelf-citationMensink, R. P., & Katan, M. B. (1990) · New England Journal of Medicine · doi:10.1056/nejm199008163230703 · Cited by 1,424 · cited 2×
“included 66 dietary interventions (‘diets’) among men and women involving a total of 518 individuals (Laine et al., 1982; Mensink and Katan, 1990; Zock and Katan, 1992; Judd et al., 1994, 1998, 2002; Almendingen et al., 1995; Aro et al., 1997; Muller et al., 1998; Lichtenstein et al., 1999; de Roos et al., 2001; Lovej…”
BackgroundIntake of trans fatty acids and risk of coronary heart disease among women
WILLETT, W. (1993) · The Lancet · doi:10.1016/0140-6736(93)90350-p · Cited by 1,025 · cited 2×
“For example, the use of objective biomarkers of TFA consumption (for example, erythrocyte membrane levels) (Sun et al., 2007) reveals stronger associations between TFA intake and CHD risk than the use of dietary questionnaires (Willett et al., 1993; Hu et al., 1997; Oh et al., 2005).”
BackgroundLipoprotein(a) and Coronary Heart Disease: Meta-Analysis of Prospective Studies
Danesh, J., Collins, R., & Peto, R. (2000) · Circulation · doi:10.1161/01.cir.102.10.1082 · Cited by 938 · cited 2×
“…TC/HDL-C, ApoB/ApoAI, Lp(a) and CRP if 7.5% of energy from PHVO were replaced with alternative fats and oils were calculated using established relationships between these risk factors and the incidence of CHD (Danesh et al., 2000, 2004; Yusuf et al., 2004; Prospective Studies Collaboration, 2007).”
BackgroundMethodInfluential
Cited by
Items 101–200 of 409
Malpuech‐Brugère, C., Mouriot, J., Vaysse, C., Combe, N., Peyraud, J.-L., Leruyet, P., Chesneau, G., Morio, B., & Chardigny, J. (2010) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2010.73 · Cited by 50
“These isomers have been reported to be more deleterious than the trans18:1 isomers (Baylin et al., 2003), for a review see Mozaffarian and Clarke (2009).”
BackgroundKliemann, N., Kraemer, M. V. D. S., Scapin, T., Rodrigues, V. M., Fernandes, A. C., Bernardo, G. L., Uggioni, P. L., & Proença, R. P. D. C. (2018) · Nutrients · doi:10.3390/nu10070891 · Cited by 54
Magri, T., Fernandes, F. S., de Souza, A. S., Prata, L. G. P. L., Barboza, T. J. D. S., Misan, V., Mucci, D. D. B., dos Santos, R. M. A. R., Nunes, T. F., de Souza, S. A. L., et al. (2014) · Clinical Nutrition · doi:10.1016/j.clnu.2014.09.014 · Cited by 42
“Changes in the composition of dietary fatty acids, which are involved in the regulation of several cellular activities, can lead to obesity [9] and other associated pathological conditions such as insulin resistance [10], hypertension, and cardiovascular disease [11,12].”
BackgroundMozaffarian, D. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv595 · Cited by 40
“The authors also adjusted for levels of blood cholesterol—a major pathway whereby TFAs would influence cardiovascular risk.(2) Such adjustment for potential ‘mediating’ variables would attenuate”
BackgroundInfluentialSelf-citationTrans ‐10 18:1 in ruminant meats: A review
Alves, S. P., Vahmani, P., Mapiye, C., McAllister, T. A., Bessa, R. J. B., & Dugan, M. E. R. (2021) · Lipids · doi:10.1002/lipd.12324 · Cited by 47
Development of “New” Bread and Cheese
Wei, W., & Yano, H. (2020) · Processes · doi:10.3390/pr8121541 · Cited by 41
Nitrogen applications modify seed and oil yields and fatty acid composition of winter mustard
Zheljazkov, V. D., Vick, B. A., Ebelhar, M. W., Buehring, N. W., & Astatkie, T. (2011) · Industrial Crops and Products · doi:10.1016/j.indcrop.2011.08.002 · Cited by 43
Rubinstein, A., Elorriaga, N., Garay, O. U., Poggio, R., Caporale, J., Matta, M. G., Augustovski, F., Pichón-Rivière, A., & Mozaffarian, D. (2015) · Bulletin of the World Health Organization · doi:10.2471/blt.14.150516 · Cited by 46
Self-citationTrans fatty acids in commercial cookies and biscuits: An update of Portuguese market
Teixeira-Santos, L., Cruz, R., & Casal, S. I. P. (2014) · Food Control · doi:10.1016/j.foodcont.2014.06.046 · Cited by 40
Unhapipatpong, C., Shantavasinkul, P. C., Kasemsup, V., Siriyotha, S., Warodomwichit, D., Maneesuwannarat, S., Vathesatogkit, P., Sritara, P., & Thakkinstian, A. (2021) · Nutrients · doi:10.3390/nu13051549 · Cited by 42
“However, palm oil substituted for TFA-rich oil consumption significantly decreased the TC/HDL-c ratio [16,17].”
BackgroundBendsen, N. T., Chabanova, E., Thomsen, H. S., Larsen, T. M., Newman, J. W. I., Stender, S., Dyerberg, J., Haugaard, S. B., & Astrup, A. V. (2011) · Nutrition and Diabetes · doi:10.1038/nutd.2010.4 · Cited by 42
From Denmark to Delhi: the multisectoral challenge of regulatingtransfats in India
Downs, S., Thow, A. M., Ghosh‐Jerath, S., McNab, J., Reddy, K. S., & Leeder, S. (2012) · Public Health Nutrition · doi:10.1017/s1368980012004995 · Cited by 42
“of trans fat has the most health benefits when replaced with polyunsaturated and monounsaturated fats rather than saturated fats((3)).”
Pande, G., Akoh, C. C., & Shewfelt, R. L. (2012) · Biocatalysis and Agricultural Biotechnology · doi:10.1016/j.bcab.2012.08.005 · Cited by 37
Ratnayake, W. N., Swist, E., Zoka, R., Gagnon, C., Lillycrop, W., & Pantazapoulos, P. (2014) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.078352 · Cited by 39
“For example, most brands of soft margarines sold in Canada in the 1990s were prepared by using PHVOs and contained TFAs ranging from 20% to 25% of total fatty acids (4–6, 8).”
BackgroundInfluentialHorn, P. J., Sturtevant, D., & Chapman, K. D. (2013) · Biochimie · doi:10.1016/j.biochi.2013.08.010 · Cited by 47
Novel Strategies for Nanostructuring Liquid Oils into Functional Fats
Zetzl, A. K., & Marangoni, A. G. (2011) · Elsevier eBooks · doi:10.1016/b978-0-9830791-1-8.50005-x · Cited by 35
Nutritional management of hyperapoB
Lamantia, V., Sniderman, A. D., & Faraj, M. (2016) · Nutrition Research Reviews · doi:10.1017/s0954422416000147 · Cited by 40
“These findings support an earlier meta-analysis published to date((81)).”
BackgroundMethodResultInfluentialPrevalência de dislipidemias e consumo alimentar: um estudo de base populacional
Valença, S. E. O., de Brito, A. D. M., da Silva, D. C. G., Ferreira, F. G., de Novaes, J. F., & Longo, G. Z. (2021) · Ciência & Saúde Coletiva · doi:10.1590/1413-812320212611.28022020 · Cited by 59
Colón‐Ramos, U., Monge‐Rojas, R., & Campos, H. (2013) · Health Policy and Planning · doi:10.1093/heapol/czt034 · Cited by 40
“However, there is very little information on the actions taken by governments to comply with the WHO’s recommendation on TFA (Mozaffarian and Clarke 2009).”
BackgroundRisk tradeoffs associated with traditional food advisories for Labrador Inuit
Calder, R. S. D., Bromage, S., & Sunderland, E. M. (2018) · Environmental Research · doi:10.1016/j.envres.2018.09.005 · Cited by 39
Decoding the Foodome: Molecular Networks Connecting Diet and Health
Menichetti, G., Barabási, A.-L., & Loscalzo, J. (2024) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-062322-030557 · Cited by 32
“This approach has led to multiple important findings, such as the negative impact of trans fats (98, 104, 155) and the beneficial effects of n -3 polyun-saturated fatty acids, legumes, and nuts on cardiovascular disease (CVD) risk (26).”
BackgroundMarangoni, F., Novo, G., Perna, G., Filardi, P. P., Pirelli, S., Ceroti, M., Querci, A., & Poli, A. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.11.048 · Cited by 36
“Saturated and trans fatty acids (FA), notably, appear to increase such risk [2], while their replacement by monounsaturated (MUFA) and, especially, polyunsaturated (PUFA) fatty acids is considered to be protective [3,4].”
BackgroundStearic acid: a possible substitute for trans fatty acids from industrial origin
Valenzuela, A., Delplanque, B., & Tavella, M. J. (2011) · Grasas y Aceites · doi:10.3989/gya.033910 · Cited by 43
“In response to these requirements, different industrial and fast food companies have announced the removal or future elimination of fats containing TFA in their products (Korver & Katan, 2006; Mozaffarian & Clarke, 2009).”
BackgroundJacobs, S., Schiller, K., Jansen, E. H. J. M., Fritsche, A., Weikert, C., di Giuseppe, R., Boeing, H., Schulze, M. B., & Kröger, J. (2015) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2015.36 · Cited by 32
Atualização da Diretriz Brasileira de Hipercolesterolemia Familiar – 2021
Izar, M. C. D. O., Rocha, V. Z., Bertolami, A., Santos, R. D., Lottenberg, A. M., Assad, M. H. V., Saraiva, J. F. K., Chacra, A. P. M., Martinez, T. L. D. R., Bahia, L., et al. (2021) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20210788 · Cited by 68
Dietary fatty acids and CD36-mediated cholesterol homeostasis: potential mechanisms
Uluğ, E., & Nergiz‐Unal, R. (2020) · Nutrition Research Reviews · doi:10.1017/s0954422420000128 · Cited by 36
“MUFA are generally thought to have positive effects on cholesterol homeostasis(95,96).”
BackgroundJacobs, S., Schiller, K., Jansen, E. H. J. M., Fritsche, A., Weikert, C., di Giuseppe, R., Boeing, H., Schulze, M. B., & Kröger, J. (2014) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2014.18 · Cited by 32
Eliminating the Use of Partially Hydrogenated Oil in Food Production and Preparation
Dietz, W. H., & Scanlon, K. S. (2012) · JAMA · doi:10.1001/jama.2012.7379 · Cited by 30
Lakum, R., & Sonwai, S. (2018) · International Journal of Food Science & Technology · doi:10.1111/ijfs.13888 · Cited by 31
Trans fatty acids in diets act as a precipitating factor for gut inflammation?
Okada, Y., Tsuzuki, Y., Ueda, T., Hozumi, H., Sato, S., Hokari, R., Kurihara, C., Watanabe, C., Tomita, K., Komoto, S., et al. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12270 · Cited by 33
Leeman, R. F., Fischler, C., & Rozin, P. N. (2011) · Appetite · doi:10.1016/j.appet.2011.01.022 · Cited by 39
“Examples include the cardiovascular benefits of limiting intake of trans-fatty acids (Mozaffarian & Clarke, 2009) and the utility of whole grains and dietary fiber consumption in limiting risk of diabetes (American Diabetes Association, 2006).”
Millen, B. E., Wolongevicz, D. M., Jesus, J. M. D., Nonas, C., & Lichtenstein, A. H. (2014) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2014.07.037 · Cited by 32
Designing Hydrocolloid-Based Oleogels With High Physical, Chemical, and Structural Stability
Bascuas, S., Salvador, A., Hernando, I., & Quiles, A. (2020) · Frontiers in Sustainable Food Systems · doi:10.3389/fsufs.2020.00111 · Cited by 28
“Several studies have reported the relationship between the negative cardiovascular effects and the increased consumption of saturated and trans-fatty acids (Mozaffarian and Clarke, 2009; Morenga and Montez, 2017).”
BackgroundSoares-Miranda, L., Stein, P. K., Imamura, F., Sattelmair, J., Lemaitre, R. N., Siscovick, D. S., Mota, J., & Mozaffarian, D. (2012) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.111.966259 · Cited by 27
“The magnitude of the observed associations between TFA consumption and cardiovascular disease events cannot be explained simply by changes in circulating lipids.(2,4) Furthermore, several different types of TFA exist, each with potentially different dietary sources and health effects.”
BackgroundSelf-citationTruthmann, J., Schienkiewitz, A., Busch, M. A., Mensink, G. B. M., Du, Y., Bosy-Westphal, A., Knopf, H., & Scheidt-Nave, C. (2016) · BMC Public Health · doi:10.1186/s12889-016-2826-2 · Cited by 27
“Other studies suggested, that the changes explain about 0.04 mmol/l [45] to 0.08 mmol/l [13] of the TC decline.”
InfluentialWilliams, L. H., Baker-Smith, C. M., Bolick, J. P., Carter, J., Kirkpatrick, C. F., Ley, S. L., Peterson, A. L. H., SHAH, A. S., Sikand, G., Ware, A. L., et al. (2022) · Journal of clinical lipidology · doi:10.1016/j.jacl.2022.07.011 · Cited by 31
Wang, Q., Bobadilla, S., Espert, M., Sanz, T., & Salvador, A. (2024) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2024.109936 · Cited by 27
Rapeseed/Canola (Brassica napus) Seed
Goyal, A., Tanwar, B., Sihag, M. K., Kumar, V., Sharma, V., & Soni, S. (2020) · Springer eBooks · doi:10.1007/978-981-15-4194-0_2 · Cited by 47
Dietary management of dyslipidaemias. Is there any evidence for cardiovascular benefit?
Anagnostis, P. G., Paschou, S. Α., Goulis, D. G., Athyros, V. G., & Karagiannis, A. I. (2017) · Maturitas · doi:10.1016/j.maturitas.2017.11.011 · Cited by 29
New approaches to triglyceride reduction: is there any hope left?
Filtz, A., Parihar, S., Greenberg, G. S., Park, C. M., Scotti, A., Lorenzatti, D., Badimon, J. J., Soffer, D. E., Toth, P. P., Lavie, C. J., et al. (2024) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2024.100648 · Cited by 26
“Among its population of patients, 67 % of which were in the secondary prevention cohort, and 96 % of whom were on a statin, there was no reduction in adverse CVD events associated with the addition of fibrate therapy despite a 26 % reduction in TG and VLDL compared to placebo [69].”
BackgroundEffect of trans Fatty Acid Intake on LC-MS and NMR Plasma Profiles
Gürdeniz, G., Rago, D., Bendsen, N. T., Savorani, F., Astrup, A. V., & Dragsted, L. O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069589 · Cited by 29
“and cardiovascular disease events cannot be explained only by changes in lipoprotein levels, triglycerides, apolipoprotein (Apo) B/ApoAI ratio and C-reactive protein [8], implying that the mechanisms behind the adverse effects of TFAs are not fully understood.”
BackgroundTeng, K., Voon, P. T., Cheng, H., & Nesaretnam, K. (2010) · Lipids · doi:10.1007/s11745-010-3416-1 · Cited by 28
“The trans fatty acids content of partially hydrogenated vegetable oils used in Iranian households is 25–35%, and up to 50% in food industries [3, 14].”
Yang, Q., Zhang, Z., Loustalot, F. V., Vesper, H. W., Caudill, S. P., Ritchey, M. D., Gillespie, C., Merritt, R. K., Hong, Y., & Bowman, B. A. (2017) · Journal of Nutrition · doi:10.3945/jn.116.245597 · Cited by 27
Pan, L., Wu, X., Luo, S., He, H., & Luo, J. (2020) · Journal of Food Science · doi:10.1111/1750-3841.15341 · Cited by 25
Babu, B. K., Mathur, R. K., Anitha, P., Ravichandran, G., & Bhagya, H. P. (2021) · Physiology and Molecular Biology of Plants · doi:10.1007/s12298-021-00964-w · Cited by 27
Engineering Nutritionally Improved Edible Plant Oils
Zhou, X., Liu, Q., & Singh, S. P. (2023) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-052720-104852 · Cited by 31
Sanders, T. A. B. (2015) · Elsevier eBooks · doi:10.1016/b978-1-78242-247-1.00001-6 · Cited by 28
The Contribution of Modern Margarine and Fat Spreads to Dietary Fat Intake
Patel, A. R., Lecerf, J., Schenker, S., & Dewettinck, K. (2016) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12198 · Cited by 32
Policies for healthy and sustainable edible oil consumption: a stakeholder analysis for Thailand
Shankar, B., Thaiprasert, N., Gheewala, S. H., & Smith, R. (2016) · Public Health Nutrition · doi:10.1017/s1368980016003037 · Cited by 31
“Fourth, there is evidence to show that rice bran oil has potentially beneficial health effects beyond those arising from its fat composition((25)).”
BackgroundDietary Risk Factors and Eating Behaviors in Peripheral Arterial Disease (PAD)
Cecchini, A. L., Biscetti, F., Rando, M. M., Nardella, E., Pecorini, G., Eraso, L. H., DiMuzio, P. J., Gasbarrini, A., Massetti, M., & Flex, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810814 · Cited by 37
“Additionally, the low consumption of foods rich in saturated fats espoused by the MD results in a decreased endogenous production of cholesterol [179].”
BackgroundTrans Fats: Health, Chemistry, Functionality, and Potential Replacement Solutions
Kodali, D. R. (2014) · Elsevier eBooks · doi:10.1016/b978-0-9830791-5-6.50006-x · Cited by 31
Frota, K. D. M. G., Matias, A. C. G., & Arêas, J. A. G. (2010) · Food Science and Technology · doi:10.1590/s0101-20612010000500002 · Cited by 31
Marklund, M., Zheng, M., Veerman, L. J., & Wu, J. H. Y. (2020) · PLoS Medicine · doi:10.1371/journal.pmed.1003407 · Cited by 26
“TFA causes cardiometabolic dysfunction [2], and a meta-analysis of prospective studies reported that for every 2% of total energy from TFAs, IHD risk increased by 23% [3].”
BackgroundBallesteros-Vásquez, M. N., Valenzuela-Calvillo, L. S., Artalejo, E., & Robles-Sardín, A. E. (2012) · Nutrición Hospitalaria · doi:10.3305/nh.2012.27.1.5420 · Cited by 62
Al‐Jawaldeh, A., & Al-Jawaldeh, H. (2018) · Children · doi:10.3390/children5070089 · Cited by 27
“TFAs are typically found in processed food, fast food, snack food, fried food, frozen pizza, pies, cookies, margarines and spreads [8,9].”
BackgroundAnalysis of the fat profile of industrialized food in Brazil with emphasis on trans-fatty acids
Aued-Pimentel, S., & Kus-Yamashita, M. M. M. (2021) · Journal of Food Composition and Analysis · doi:10.1016/j.jfca.2020.103799 · Cited by 25
Downs, S., & Fanzo, J. (2015) · Current Nutrition Reports · doi:10.1007/s13668-015-0142-6 · Cited by 30
Reappraisal of SFA and cardiovascular risk
Sanders, T. A. B. (2013) · Proceedings of The Nutrition Society · doi:10.1017/s0029665113003364 · Cited by 25
Trumbo, P. R., & Shimakawa, T. (2011) · Nutrition Reviews · doi:10.1111/j.1753-4887.2011.00389.x · Cited by 26
Structured Emulsions and Edible Oleogels as Solutions to Trans Fat
Zetzl, A. K., & Marangoni, A. G. (2014) · Elsevier eBooks · doi:10.1016/b978-0-9830791-5-6.50015-0 · Cited by 22
Olive Oil: Antioxidant Compounds and Their Potential Effects over Health
Kabaran, S. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.80993 · Cited by 31
“Replacement of partially hydrogenated vegetable oil with MUFA had positive impact on cardiovascular risk parameters, such as LDL cholesterol, TG, Apo-A1 and Apo-B levels [23].”
BackgroundMagriplis, E., Marakis, G. N., Kotopoulou, S., Naska, A., Michas, G., Micha, R., Panagiotakos, D. B., & Zampelas, A. (2022) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2304130 · Cited by 26
“…adverse health effects, disrupting circulating lipid biomarkers; specifically increasing LDL-cholesterol, lipoprotein (little) a (Lp α ) and tria-cylglycerol levels, decreasing HDL-cholesterol levels and LDL-cholesterol particle size [9,10], but also increasing total-/HDL-cholesterol ratio [11].”
BackgroundBhavsar, N., & St‐Onge, M. (2016) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000249 · Cited by 26
“Replacing trans fatty acids from hydrogenated oils with SFA has been shown to be beneficial [39].”
BackgroundLichtenstein, A. H. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-375083-9.00097-0 · Cited by 36
Krogager, T. P., Nielsen, L. V., Kahveci, D., Dyrlund, T. F., Scavenius, C., Sanggaard, K. W., & Enghild, J. J. (2015) · Proteome Science · doi:10.1186/s12953-015-0084-3 · Cited by 26
“It has previously been established that iTFAs correlate with CVD risk [3].”
BackgroundSaghafi, Z., Naeli, M. H., Tabibiazar, M., & Zargaraan, A. (2018) · Journal of the American Oil Chemists Society · doi:10.1002/aocs.12033 · Cited by 21
Yang, Z., Amar, M. J., Sorokin, A. V., Troendle, J. F., Courville, A. B., Sampson, M. L., Playford, M. P., Yang, S. B., Stagliano, M. S., Ling, C., et al. (2019) · Journal of clinical lipidology · doi:10.1016/j.jacl.2019.10.013 · Cited by 26
Oxidative Stability and Shelf Life of Frying Oils and Fried Foods
Hwang, H., & Winkler‐Moser, J. K. (2016) · Elsevier eBooks · doi:10.1016/b978-1-63067-056-6.00007-0 · Cited by 24
Kakde, S., Bhopal, R. S., Bhardwaj, S., & Misra, A. (2016) · Nutrition · doi:10.1016/j.nut.2016.07.006 · Cited by 24
Shibamoto, S., Murata, T., & Yamamoto, K. (2016) · Lipids · doi:10.1007/s11745-016-4180-7 · Cited by 23
Plant-based cheese analogs: structure, texture, and functionality
Atik, D. S., & Huppertz, T. (2025) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2024.2449234 · Cited by 32
“Hydrogenation drastically diminishes the nutritional value of plant lipids and raises the risk of coronary heart disease and cardiovascular disease as a result of the creation of trans fatty acids (Mozaffarian and Clarke 2009).”
Downs, S., Gupta, V., Ghosh‐Jerath, S., Lock, K., Thow, A. M., & Singh, A. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-1139 · Cited by 27
“communicable diseases (NCDs), especially cardiovascular disease (CVD) [1-4].”
BackgroundTrans fatty acids and cholesterol levels: An evidence map of the available science
Liska, D. J., Cook, C. M., Wang, D. D., Gaine, P. C., & Baer, D. J. (2016) · Food and Chemical Toxicology · doi:10.1016/j.fct.2016.07.002 · Cited by 26
Brouwer, I. A. (2020) · Nutrition Bulletin · doi:10.1111/nbu.12449 · Cited by 26
Esmaillzadeh, A., & Azadbakht, L. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114510004423 · Cited by 20
“The effects of a higher trans-fat intake on serum TAG and total cholesterol levels have also been documented((41)).”
BackgroundMakeri, M. U., Karim, R., Abdulkarim, M. S., Ghazali, H. M., Sahri, M. M., & Muhammad, K. (2015) · International Journal of Food Properties · doi:10.1080/10942912.2015.1031246 · Cited by 20
“Solid fat content is one of the key properties of fats meant for making margarines, spreads, and other plastic fats used in bread and confectionery manufacture, usually obtained through partial hydrogenation of oils, which generates trans-FAs that are implicated in coronary heart diseases.([42,43]) The SFC of WBO plac…”
BackgroundSmuts, C. M., & Wolmarans, P. (2013) · South African Journal of Clinical Nutrition · doi:10.1080/16070658.2013.12519344 · Cited by 37
Makarewicz‐Wujec, M., Dworakowska, A. M., & Kozłowska−Wojciechowska, M. (2018) · Public Health Nutrition · doi:10.1017/s1368980018000782 · Cited by 22
“In a meta-analysis of numerous studies, Mozaffarian and Clarke concluded that intake of 1% of energy from TFA in place of other fats increases TC:HDL-C by 0·022 if SFA are replaced; by 0·051 if MUFA are replaced; and by 0·057 if PUFA are replaced((8)).”
Hu, S.-B., Zou, Q., Lv, X., Zhou, R., Xian, N., Weng, C., Chen, F., Fan, Y., Deng, Z., & Li, J. (2019) · Food & Function · doi:10.1039/c9fo01982k · Cited by 20
Brai, A., Poggialini, F., Trivisani, C. I., Vagaggini, C., Tarchi, F., Francardi, V., & Dreassi, E. (2022) · Journal of Insects as Food and Feed · doi:10.3920/jiff2022.0090 · Cited by 20
Lefevre, M., Mensink, R. P., Kris‐Etherton, P. M., Petersen, B. J., Smith, K. M., & Flickinger, B. D. (2012) · Lipids · doi:10.1007/s11745-012-3705-y · Cited by 22
“Based on changes in FA classes (and not individual FA) and published regression coefficients from prospective studies [23], our data would predict a reduction in CVD events of 11 % in the middle and 29 % in the upper quintiles of TFA users under the complete replacement model.”
ResultNutritional Profiles in a Public Health Perspective: A Critical Review
Foltran, F., Verduci, E., Ghidina, M., Campoy, C., Jany, K.-D., Widhalm, K., Biasucci, G., Vögele, C., HALPERN, G. M., & Gregori, D. (2010) · Journal of International Medical Research · doi:10.1177/147323001003800202 · Cited by 22
Biesiekierska, M., Strigini, M., Śliwińska, A., Pirola, L., & Balcerczyk, A. (2025) · Nutrition Reviews · doi:10.1093/nutrit/nuaf010 · Cited by 18
Demin, A., Løge, B., Zhiteneva, O., Nishida, C., Whiting, S., Rippin, H. L., Delles, C., Karymbaeva, S. T., Wickramasinghe, K. K., & Breda, J. (2020) · Journal of Clinical Hypertension · doi:10.1111/jch.13945 · Cited by 18
Consumption Safety of Pastries, Confectioneries, and Potato Products as Related to Fat Content
Żbikowska, A., Rutkowska, J., & Kowalska, M. K. (2015) · Journal of the American College of Nutrition · doi:10.1080/07315724.2014.942472 · Cited by 19
“2g TFA/100 g FA) in fats from confectioneries, pastries, and potato products was noted and this was also reported by authors from other countries [10,35,36,38].”
BackgroundResultSex-dimorphism in Cardiac Nutrigenomics: effect of Trans fat and/or Monosodium Glutamate consumption
Collison, K. S., Zaidi, M. Z., Maqbool, Z. M., Saleh, S. M., Inglis, A. L., Makhoul, N. J., Bakheet, R., Shoukri, M. M., & Al-Mohanna, F. A. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-555 · Cited by 18
“Cardiac hypertrophy and CHD are mediated by transcription factor integration of upstream stress signals, and Mef2d-deficient mice have an attenuated hypertrophic response to cardiac stress [34].”
BackgroundInfluentialAnalysis and Formation of trans Fatty Acids in Corn Oil During the Heating Process
Yang, M., Yang, Y., Nie, S., Xie, M., & Chen, F. (2011) · Journal of the American Oil Chemists Society · doi:10.1007/s11746-011-1974-x · Cited by 17
EFSA Panel on Dietetic Products, N. A. A. (. (2011) · EFSA Journal · doi:10.2903/j.efsa.2011.2168 · Cited by 20
Detry, R., Hoed, V. V., Sterckx, J., Deledicque, C., Sato, K., Blecker, C. S., & Danthine, S. (2020) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.202000155 · Cited by 17
Sarda, B., Kesse‐Guyot, E., Srour, B., Deschasaux, M., Fialon, M., Fezeu, L., Galan, P., Herçberg, S., Touvier, M., & Julia, C. (2024) · BMJ Global Health · doi:10.1136/bmjgh-2023-014162 · Cited by 19
Colmenárez, P. J. M., Illán-Marcos, E., Díaz-Cruces, E., Rocasolano, M. M., Martínez-Hernandez, J. M., Zamora-Ledezma, E., & Zamora‐Ledezma, C. (2024) · Foods · doi:10.3390/foods13233845 · Cited by 16
“Industrial trans fats are artificially produced during the hydrogenation process of vegetable oils, which increases their shelf life and enhances their flavor [27].”
InfluentialMeta-regression analysis of the effect of trans fatty acids on low-density lipoprotein cholesterol
Allen, B. C., Vincent, M., Liska, D. J., & Haber, L. T. (2016) · Food and Chemical Toxicology · doi:10.1016/j.fct.2016.10.014 · Cited by 17
“It is noted, however, that the determination of appropriate lipoprotein biomarkers is an area of active scientific discussion, with lipids outcomes such as HDL-C and non-HDL-C under consideration as emergingmarkers.”
BackgroundMethodResultInfluentialValenzuela, C. A., Baker, E. J., de Souza, C. O., Miles, E. A., & Calder, P. C. (2021) · Molecules · doi:10.3390/molecules26195834 · Cited by 16
Turpeinen, A. M., & Merimaa, P. (2011) · Elsevier eBooks · doi:10.1533/9780857092557.3.383 · Cited by 17
Pande, G., Akoh, C. C., & Shewfelt, R. L. (2012) · Journal of Food Science · doi:10.1111/j.1750-3841.2012.02935.x · Cited by 16
“creased LDL, decreased HDL, and increased total:HDL cholesterol (Mozaffarian and Clarke 2009) and cancer (Astorg 2005).”
BackgroundTorrejón, C., & Uauy, R. D. (2011) · Revista médica de Chile · doi:10.4067/s0034-98872011000700016 · Cited by 18
Zhang, Z., Gillespie, C., & Yang, Q. (2017) · Nutrition Research · doi:10.1016/j.nutres.2017.05.008 · Cited by 17
Desjardins, L.-C., Brière, F., Tremblay, A. J., Rancourt-Bouchard, M., Drouin‐Chartier, J., Corbeil, J., Lemelin, V., Charest, A., Schaefer, E. J., Lamarche, B., et al. (2024) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2024.03.015 · Cited by 16
Food Additives Reducing Volatility of Antioxidants at Frying Temperature
Hwang, H., & Winkler‐Moser, J. K. (2014) · Journal of the American Oil Chemists Society · doi:10.1007/s11746-014-2525-z · Cited by 16
Mono unsaturated fatty acids for CVD and diabetes: A healthy choice
Kuna, A., & Poshadri, A. (2013) · International journal of Nutrition Pharmacology Neurological Diseases · doi:10.4103/2231-0738.114841 · Cited by 17
Metadata
- Authors
- Mozaffarian, D., & Clarke, R.
- Affiliations
- Brigham and Women's Hospital (US)
- University of Oxford (GB)
- Corresponding author
- Mozaffarian, D
- Venue
- European Journal of Clinical Nutrition
- Published
- 2009-05
- Volume
- 63
- Issue
- S2
- Pages
- S22-S33
- ISSN
- 0954-3007 (ISSN-L)
- 1476-5640
- OpenAlex
- W2053223480
- Cited by
- 410
- References
- 44
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 19 · 2023: 16 · 2022: 13 · 2021: 27 · 2020: 30 · 2019: 19 · 2018: 16 · 2017: 18 · 2016: 27 · 2015: 33 · 2014: 35 · 2013: 35 · 2012: 42
- FWCI
- 34.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- European Journal of Clinical Nutrition (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fonterra Co-Operative Group
- National Institutes of Health (1k08hl075628-01)
- National Heart, Lung, and Blood Institute (K08-HL-075628)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- trans fatty acids, partially hydrogenated vegetable oils, coronary heart disease risk, fat replacement, saturated fatty acids, monounsaturated fatty acids, polyunsaturated fatty acids, serum lipids, lipoproteins, apolipoprotein B/apolipoprotein A-I ratio, lipoprotein(a), C-reactive protein, butter, lard, palm oil, vegetable oils, canola
- MeSH terms
- Animals, C-Reactive Protein, Cardiovascular Diseases, Cholesterol, Coronary Disease, Dietary Fats, Fatty Acids, Humans, Hydrogenation, Lipids, Plant Oils, Risk Factors, Trans Fatty Acids, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.